Cargando…

Persistence and Changing Distribution of Leishmaniases in Kenya Require a Paradigm Shift

BACKGROUND: Leishmaniases present a major global public health problem, being responsible for between 40,000 and 50,000 deaths annually. The resultant morbidity affects the economic productivity and quality of life of individuals in endemic regions. As zoonotic disease(s), leishmaniases have become...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouma, Francan F., Mulambalah, Chrispinus S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545581/ https://www.ncbi.nlm.nih.gov/pubmed/34707907 http://dx.doi.org/10.1155/2021/9989581

Ejemplares similares

The Burden of Cystic Echinococcosis in Kenya: A Review Article
por: KIA, Eshrat Beigom, et al.
Publicado: (2019)

The leishmaniases in Kenya: A scoping review
por: Grifferty, Grace, et al.
Publicado: (2023)

Global distribution maps of the leishmaniases
por: Pigott, David M, et al.
Publicado: (2014)

Malaria and Geohelminthiasis Coinfections in Expectant Women: Effect on Maternal Health and Birth Outcomes in a Malaria Endemic Region in Kenya
por: Wanyonyi, Wekesa Antony, et al.
Publicado: (2018)

Shotgun Metagenomic Analyses of Microbial Assemblages in the Aquatic Ecosystem of Winam Gulf of Lake Victoria, Kenya Reveals Multiclass Pollution
por: Khatiebi, Sandra, et al.
Publicado: (2023)

Management of Leishmaniases in the Era of Climate Change in Morocco
por: Kholoud, Kahime, et al.
Publicado: (2018)

Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review
por: Grifferty, Grace, et al.
Publicado: (2021)

Comparative genomics: From genotype to disease phenotype in the leishmaniases
por: Smith, Deborah F., et al.
Publicado: (2007)

Leishmaniases diagnosis: an update on the use of immunological and molecular tools
por: de Paiva-Cavalcanti, Milena, et al.
Publicado: (2015)

Leishmania tarentolae: A new frontier in the epidemiology and control of the leishmaniases
por: Mendoza‐Roldan, Jairo Alfonso, et al.
Publicado: (2022)

Leishmaniases in the European Union and Neighboring Countries
por: Berriatua, Eduardo, et al.
Publicado: (2021)

Liposomal Amphotericin B Treatment and the Leishmaniases
por: Berman, Jonathan
Publicado: (2019)

Screening for rheumatic heart disease: is a paradigm shift required?
por: Hunter, L D, et al.
Publicado: (2017)

Vaccines for the Leishmaniases: Proposals for a Research Agenda
por: Costa, Carlos Henrique Nery, et al.
Publicado: (2011)

A Critical Overview of Interleukin 32 in Leishmaniases
por: Ribeiro-Dias, Fátima, et al.
Publicado: (2022)

An overview of the sand fly salivary proteins in vaccine development against leishmaniases
por: Fayaz, Shima, et al.
Publicado: (2022)

One Health Approach to Leishmaniases: Understanding the Disease Dynamics through Diagnostic Tools
por: Hong, Ahyun, et al.
Publicado: (2020)

Commercial Rabbit Farming and Poverty in Urban and Peri-Urban Kenya
por: Mutsami, Chrispinus, et al.
Publicado: (2020)

Persisting symptoms after concussion: Time for a paradigm shift
por: Broshek, Donna K., et al.
Publicado: (2022)

Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021—A Comprehensive Review
por: Rocha, Rafael, et al.
Publicado: (2022)

Dietary requirements of synthesizable amino acids by animals: a paradigm shift in protein nutrition
por: Wu, Guoyao
Publicado: (2014)

Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases
por: Reis, Luiza C., et al.
Publicado: (2021)

Analysis of Universal Health Coverage and Equity on Health Care in Kenya
por: Okech, Timothy Chrispinus, et al.
Publicado: (2016)

Paradigm shift: cognitive surgery
por: Kenngott, Hannes G., et al.
Publicado: (2017)

Leishmaniases' Burden of Disease: Ways Forward for Getting from Speculation to Reality
por: Reithinger, Richard
Publicado: (2008)

In Vitro Antiparasitic Activities of Monovalent Ionophore Compounds for Human and Canine Leishmaniases
por: Calvo Alvarez, Estefanía, et al.
Publicado: (2022)

Paradigm Shift or Shifting Paradigm for Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2012)

PET/MR: a paradigm shift
por: Gaertner, Florian C., et al.
Publicado: (2013)

Target Product Profile for a point-of-care diagnostic test for dermal leishmaniases
por: Cruz, Israel, et al.
Publicado: (2019)

Utilising a novel surveillance system to enhance field screening activities for the leishmaniases
por: Panahi, Elina, et al.
Publicado: (2020)

Shifting Sugars and Shifting Paradigms
por: Siegal, Mark L.
Publicado: (2015)

Emerging Viruses in the Felidae: Shifting Paradigms
por: O’Brien, Stephen J., et al.
Publicado: (2012)

Intestinal Helminth Infections in Pregnant Women Attending Antenatal Clinic at Kitale District Hospital, Kenya
por: Wekesa, A. W., et al.
Publicado: (2014)

Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases
por: Monteiro, Lis Marie, et al.
Publicado: (2017)

Editorial: Leishmania genome variability: Impacts on parasite evolution, parasitism and leishmaniases control
por: Tosi, Luiz R. O., et al.
Publicado: (2023)

Gene Therapy: A Paradigm Shift in Dentistry
por: Siddique, Nida, et al.
Publicado: (2016)

Cooperate! A paradigm shift for health equity
por: Chang, Wei-Ching, et al.
Publicado: (2017)

A New Paradigm Shift in Gastroparesis Management
por: Mekaroonkamol, Parit, et al.
Publicado: (2022)

RNA Therapeutics: A Healthcare Paradigm Shift
por: Niazi, Sarfaraz K.
Publicado: (2023)

A paradigm shift
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_chcrjrj3na1607k7uev6aa9m97